CAC2 Webinar–Dr. Jeffrey Skolnik, Basics of Pediatric Drug Development

On Wednesday, November 12, CAC2 had the privilege of hosting Jeffrey Skolnik, MD, US Medical Affairs Leader, Oncology, GlaxoSmithKline and Attending Physician, Children’s Hospital of Philadelphia. He presented our November All-Member webinar about the industry perspective in pediatric oncology drug development.   The views he expresses are his personal observations and not the official position of GSK or any other pharmaceutical company. Read more

Pediatric Cancer: Major Advances, Major Challenges – Notes from the 5th Annual Childhood Cancer Caucus

The Congressional Childhood Cancer Caucus Presents Pediatric Cancer: Major Advances, Major Challenges 5th Annual Childhood Cancer Caucus Friday, September 19, 2014 9:00 – 10:30 a.m. Congressional Auditorium, US Capitol Visitors Center Co-Chairs: Congressman Michael T. McCaul (R-TX) Congressman Chris Van Hollen (D-MD) Keynote speaker: Dr. Francis Collins, Director, National Institutes of Health (NIH) Speakers: Dr. Ronald DePinho, President, MD Anderson Cancer Center Dr. Amrit Ray, Chief Medical Officer, Johnson & Johnson – Janssen Pharmaceuticals Notes: by CAC2 Member Laurie Orloski Opening remarks Vickie Buenger, President of the Coalition of Childhood Cancer (CAC2) Vickie Buenger kicked off the Caucus by welcoming […]

Read more

CAC2 Webinar–Dr. Peter Adamson and Danielle Leach–NCI Funding and Action Day–SLIDE DECKS

On May 22, we were privileged to host Dr. Peter Adamson speaking on the history and outlook for NCI Funding and Danielle Leach providing an overview for in-person and virtual participation in the Alliance for Childhood Cancer Action Day coming up next month. Thanks to both of these articular guests for their thoughtful and insightful answers to all of our questions. Peter Adamson's Slide Deck Danielle Leach's Slide Deck Read more

NCI Meeting Scheduled for Fri. Feb 21

There will be a meeting next week at the National Cancer Institute (NCI) dedicated to pediatric cancer drug development. The National Cancer Institute (NCI) will hold its 64th Meeting of the Director’s Consumer Liaison Group (DCLG) on Friday, February 21, 2014 from 9:30 a.m. to 4:00 p.m. on the National Institutes of Health (NIH) Campus in Bethesda, MD. The meeting will focus on barriers to drug development in pediatric cancer research and will include participants from the pediatric cancer advocacy community, as well as private and public sector presenters. The panels will discuss the State of Pediatric Cancer Research, Potential […]

Read more